(Q34530386)

2 August 2017

1 reference

title

Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents (English)

1 reference

2 August 2017

0 references

0 references

Pius S Fasinu

1

0 references

author name string

Sarah Phillips

series ordinal

2

1 reference

2 August 2017

Mahmoud A ElSohly

series ordinal

3

1 reference

2 August 2017

Larry A Walker

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

10 June 2016

1 reference

2 August 2017

1 reference

2 August 2017

36

1 reference

2 August 2017

7

1 reference

2 August 2017

781-796

1 reference

History of cannabis and its preparations in saga, science, and sobriquet

2 August 2017

1 reference

Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis

21 January 2018

1 reference

Cannabis, a complex plant: different compounds and different effects on individuals

21 January 2018

1 reference

Biologically active cannabinoids from high-potency Cannabis sativa

21 January 2018

1 reference

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

21 January 2018

1 reference

Phytocannabinoids beyond the Cannabis plant - do they exist?

21 January 2018

1 reference

Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I

21 January 2018

1 reference

Hashish. I. The structure of cannabidiol

21 January 2018

1 reference

History of cannabis as a medicine: a review

21 January 2018

1 reference

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

21 January 2018

1 reference

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

21 January 2018

1 reference

Cannabinoids, endocannabinoids, and cancer

21 January 2018

1 reference

Cannabis with high cannabidiol content is associated with fewer psychotic experiences.

21 January 2018

1 reference

Controlled clinical trial of cannabidiol in Huntington's disease

21 January 2018

1 reference

Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.

21 January 2018

1 reference

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

21 January 2018

1 reference

Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.

21 January 2018

1 reference

Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries

21 January 2018

1 reference

Cannabis, cannabidiol, and epilepsy--from receptors to clinical response

21 January 2018

1 reference

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

21 January 2018

1 reference

Current therapeutic procedures in Dravet syndrome.

21 January 2018

1 reference

The Lennox-Gastaut syndrome

21 January 2018

1 reference

Treatment of Lennox-Gastaut Syndrome (LGS).

21 January 2018

1 reference

Stiripentol: an example of antiepileptic drug development in childhood epilepsies.

21 January 2018

1 reference

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

21 January 2018

1 reference

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

21 January 2018

1 reference

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

21 January 2018

1 reference

Cannabidiol monotherapy for treatment-resistant schizophrenia

21 January 2018

1 reference

Cannabidiol for the treatment of psychosis in Parkinson's disease

21 January 2018

1 reference

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

21 January 2018

1 reference

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.

21 January 2018

1 reference

Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PHAR.1780

1 reference

2 August 2017

1 reference